— Know what they know.
Not Investment Advice
Also trades as: EQRXW (NASDAQ) · $vol 0M

EQRX NASDAQ

EQRx, Inc.
1W: +0.0% 1M: +5.4% 3M: +4.5% 1Y: -57.9%
$2.34
Last traded 2023-11-09 — delisted
NASDAQ · Healthcare · Biotechnology · $1.1B mcap · 279M float · 1.61% daily turnover

Cash Flow Trends

Operating Cash Flow
-$287M -56.8% ▼
Capital Expenditures
$1M -152.9% ▼
3Y CAGR: +1591.8%
Free Cash Flow
-$288M -57.1% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$1.2B -199.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$26K-$250M-$100M-$169M
Depreciation & Amort.$0$338K$1M$935K
Stock-Based Comp.$0$346K$26M$42M
Change in Working Capital$0$8M-$15M$11M
Other Non-Cash Items$18K$222K-$87M-$172M
Operating Cash Flow-$8K-$242M-$183M-$287M
— Investing Activities —
Capital Expenditures-$234-$3M-$448K-$1M
Acquisitions (Net)$0$0$0$896K
Investment Purchases$0$0-$4M-$1.4B
Investment Sales$0$0$0$510M
Other Investing$0$0$0-$896K
Investing Cash Flow-$234-$3M-$4M-$897M
— Financing Activities —
Net Debt Issuance$0$0$0$0
Stock Repurchased$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing$66K$715M$1.4B$139K
Financing Cash Flow$66K$715M$1.4B$139
Net Change in Cash$58K$471M$1.2B-$1.2B
Cash End of Period$58K$490M$1.7B$495M
Free Cash Flow-$8K-$244M-$184M-$288M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms